Silvia Steyrer-Gruber

Silvia Steyrer-Gruber has extensive work experience in the pharmaceutical industry, holding various leadership roles throughout their career. Silvia is currently the Chief Executive Officer at Coriolis Pharma since April 2022. Prior to this, they served as the Managing Director Europe at Exeltis from December 2019 to March 2022. Silvia also had multiple roles at Exeltis, including General Manager Germany and Austria, Global Head of Commercial Excellence, and Head of Western Europe.

Before joining Exeltis, Silvia worked at Baxter Healthcare, where they held positions such as Business Unit Director Vaccines Germany, Austria, Switzerland, Business Unit Director Vaccines Germany, Senior Director Vaccines; Global Marketing and Commercial Europe, and Director Global Marketing Vaccines. Silvia started their career at Kwizda Pharma as a Business Unit Manager Hospital.

Silvia also gained experience as a Senior Marketing Manager Europe, Vaccines, at Baxter and worked as a Consultant at Mercuri Urval. Their early career includes a role as Business Unit Manager Neurology at Serono.

Overall, Silvia Steyrer-Gruber has held various leadership and managerial positions in the pharmaceutical industry, showcasing their expertise and dedication in this field.

Silvia Steyrer-Gruber attended Leopold-Franzens Universität Innsbruck from 1991 to 1996. During their time there, they focused on International Business Administration. In 1993-1994, they also studied at Universidad de Zaragoza, specializing in Empresariales. Silvia's education history also includes attending Ursulinen, although the specific dates and area of study for this institution are not provided.